The present data indicated that overexpressing HOXA6 further increased the PBX2 overexpression-induced increase in GC cell invasion and migration, whereas the ectopic expression of HOXA6 in cells treated with PBX2 siRNA or PBX2 in cells treated with HOXA6 siRNA inhibited cell migration and invasion. The gene discussed is PBX2; the disease is gastric cancer.